[Double-blind trial of oral clodronate in breast cancer patients with bone metastases].
Paterson
A H
AH
Department of medicine, Tom Baker cancer centre, university of Calgary, Edmonton, Canada.
Powles
T J
TJ
Kanis
J A
JA
McCloskey
E
E
Hanson
J
J
Ashley
S
S
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002118:Calcium / Q000097:blood / Q000652:urine; D004002:Clodronic Acid / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008875:Middle Aged; D010014:Osteolysis / Q000517:prevention & control
D004002:Clodronic Acid; D002118:Calcium
Essai en double aveugle du clodronate per os chez des patientes atteintes d'un cancer du sein avec métastases osseuses.